Anti-CCL8/ HC14/ MCP-2 functional antibody

Anti-CCL8/ HC14/ MCP-2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCL8/CCL8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0751-Ab-1/ GM-Tg-hg-SE0751-Ab-2Anti-Human CCL8 monoclonal antibodyHuman
GM-Tg-rg-SE0751-Ab-1/ GM-Tg-rg-SE0751-Ab-2Anti-Rat CCL8 monoclonal antibodyRat
GM-Tg-mg-SE0751-Ab-1/ GM-Tg-mg-SE0751-Ab-2Anti-Mouse CCL8 monoclonal antibodyMouse
GM-Tg-cynog-SE0751-Ab-1/ GM-Tg-cynog-SE0751-Ab-2Anti-Cynomolgus/ Rhesus macaque CCL8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0751-Ab-1/ GM-Tg-felg-SE0751-Ab-2Anti-Feline CCL8 monoclonal antibodyFeline
GM-Tg-cang-SE0751-Ab-1/ GM-Tg-cang-SE0751-Ab-2Anti-Canine CCL8 monoclonal antibodyCanine
GM-Tg-bovg-SE0751-Ab-1/ GM-Tg-bovg-SE0751-Ab-2Anti-Bovine CCL8 monoclonal antibodyBovine
GM-Tg-equg-SE0751-Ab-1/ GM-Tg-equg-SE0751-Ab-2Anti-Equine CCL8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0751-Ab-1/ GM-Tg-hg-SE0751-Ab-2; GM-Tg-rg-SE0751-Ab-1/ GM-Tg-rg-SE0751-Ab-2;
GM-Tg-mg-SE0751-Ab-1/ GM-Tg-mg-SE0751-Ab-2; GM-Tg-cynog-SE0751-Ab-1/ GM-Tg-cynog-SE0751-Ab-2;
GM-Tg-felg-SE0751-Ab-1/ GM-Tg-felg-SE0751-Ab-2; GM-Tg-cang-SE0751-Ab-1/ GM-Tg-cang-SE0751-Ab-2;
GM-Tg-bovg-SE0751-Ab-1/ GM-Tg-bovg-SE0751-Ab-2; GM-Tg-equg-SE0751-Ab-1/ GM-Tg-equg-SE0751-Ab-2
Products NameAnti-CCL8 monoclonal antibody
Formatmab
Target NameCCL8
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCL8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0751-Ag-1Recombinant multi-species CCL8/ HC14/ MCP-2 protein
    CytokineGM-Tg-g-SE0751-Ag-1chemokine (C-C motif) ligand 8 (CCL8) protein
    ORF Viral VectorvGMLP000800human CCL8 Lentivirus particle
    ORF Viral VectorpGMLP000800human CCL8 Lentivirus plasmid
    ORF Viral VectorpGMLPm000048mouse Ccl8 Lentivirus plasmid
    ORF Viral VectorvGMLPm000048mouse Ccl8 Lentivirus particle


    Target information

    Target IDGM-SE0751
    Target NameCCL8
    Gene ID6355,574179,101097189
    Gene Symbol and SynonymsCCL8,HC14,MCP-2,MCP2,SCYA10,SCYA8
    Uniprot AccessionP80075
    Uniprot Entry NameCCL8_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000108700
    Target ClassificationN/A

    The target: CCL8, gene name: CCL8, also named as HC14, MCP-2, MCP2, SCYA10, SCYA8. This antimicrobial gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes, lymphocytes, basophils and eosinophils. By recruiting leukocytes to sites of inflammation this cytokine may contribute to tumor-associated leukocyte infiltration and to the antiviral state against HIV infection. [provided by RefSeq, Sep 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.